already indicated about new pharma policy which is not favourable for Indian pharma companies . 5.Crude is trading above $50 since long time 6.Market valuation too is not so attractive 7.Comming states election have added some uncertainty All above glaring facts are being ignored and market
1.18 PM Jan 18th
the strong fundamentals of ashok alcochem, combined with low market valuation and bullish chart pattern indicate a clear break-out. this shall reach 150 levels anytime. this is report bumper results from trading of bauxite and aluminium. look at any metal sector for cues. strong buy.
3.24 PM Jan 11th
Shares of Jubilant Life Sciences today ended with over 12 per cent gains, adding Rs 1,224.82 crore to its market valuation, after the company said its subsidiary has signed long-term contracts in the US for supply of some of its diagnostic and therapeutic products.
5.00 PM Jan 4th
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.